Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43.1M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
26M
-
Shares change
-
+789K
-
Total reported value, excl. options
-
$798M
-
Value change
-
+$23.2M
-
Number of buys
-
37
-
Number of sells
-
-27
-
Price
-
$30.69
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q1 2021
78 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q1 2021.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26M shares
of 43.1M outstanding shares and own 60.37% of the company stock.
Largest 10 shareholders include BVF INC/IL (3.72M shares), ORBIMED ADVISORS LLC (3.43M shares), FMR LLC (2.77M shares), Redmile Group, LLC (2.67M shares), MPM ASSET MANAGEMENT LLC (2.6M shares), CHI Advisors LLC (2.56M shares), MPM Oncology Impact Management LP (2.07M shares), ARK Investment Management LLC (1.36M shares), Logos Global Management LP (900K shares), and Artal Group S.A. (550K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.